Answers are grounded in this paper and cite their sources.
High renin-angiotensin system activity is a marker and potential mechanism for elevated cardiovascular risk in essential hypertension, supporting targeted therapy with ACE inhibitors and ARBs.
The importance of the renin-angiotensin system (RAS) in blood pressure regulation is well established. High RAS activity has also been implicated in connection with elevated cardiovascular risk in patients with essential hypertension. Data from epidemiological studies have related high plasma renin levels in essential hypertensive patients to cardiovascular complications. However, whether renin itself is a risk factor of cardiovascular events or just acts as a marker for other risk factors still remains to be elucidated. Several possible mechanisms that could be responsible for the association between elevated RAS activity and cardiovascular risk are reviewed. The concept of high RAS activity being a cardiovascular risk factor is strongly supported by results from large clinical studies showing the beneficial effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in congestive heart failure and hypertension. Knowing more about the exact mechanisms of the association between high RAS activity and cardiovascular complications would enable us to profile the treatment of high blood pressure more specifically to improve outcome in individuals or groups of patients.
No takes yet. Share an insight, caveat, or question.
TRIIN PARIK KRISTINA ALLIKMETS (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: